Delivery Order SPE2DB24D2212-SPE2DB25FHPCH

Award Date 3/3/25
Potential Completion Date 3/4/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,928.77 firm fixed-price delivery order is for the supply of VERQUVO 10 MG TABLET 90S, a pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,079.12 Firm Fixed Price Delivery Order contract is for the supply of VERQUVO 5 MG TABLET 30S, a pharmaceutical product, with a period of performance through February 26, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, valued at $3,798.63, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VERQUVO 10 MG TABLET 30S, a medical product, with a period of performance through October 31, 2024. This award is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,155.06 Firm Fixed Price Delivery Order contract is for the supply of VERQUVO 5 MG TABLET UD 100S, a pharmaceutical product, to support military healthcare programs. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,635.25 fixed-price delivery order contract is for the supply of VERQUVO 10 MG TABLET 90S, a medical product. The contract has an ultimate completion date of January 11, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA). The $1,091.70 firm fixed-price delivery order is for the supply of VERQUVO 10 MG TABLET 90S, a pharmaceutical product. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,704.60 firm-fixed-price delivery order is for the supply of VERQUVO 2.5 MG TABLET 30S medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award, valued at $1,354.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of VERQUVO 2.5 MG TABLET 30S, with an ultimate completion date of January 6, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,424.35 Firm Fixed Price Delivery Order covers the supply of VERQUVO 2.5 MG TABLET 30S, a medical product, to support federal healthcare programs. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,467.93 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract is for the supply of VERQUVO 2.5 MG TABLET 30S, a pharmaceutical product, with a period of performance through May 22, 2024. AmerisourceBergen holds a significant $999,999,999...
  • SPE2DB24D2212
    Indefinite Delivery Contract
  • SPE2DB24D2212-SPE2DB25FHPCH
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,240.43 firm fixed-price delivery order covers the supply of VERQUVO 10 MG TABLET 90S, a pharmaceutical product, to support federal healthcare programs.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally. This IDC encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract does not have a set-aside designation, indicating open competition.

Generated 6/2/25, 9:54 AM